Top health and wellness news from Minnesota

Provided by AGP

Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

Press releases published on May 4, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
REGIONAL HEALTH PROPERTIES ANNOUNCES APPOINTMENT OF MARLIE DAVIS AS CHIEF FINANCIAL OFFICER
Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
CooperCompanies Appoints Paul Keel to its Board of Directors
InspireMD Reports First Quarter 2026 Financial Results
Option Care Health to Participate in the Bank of America Health Care Conference
Kyntra Bio to Report First Quarter 2026 Financial Results
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
Biodesix Announces First Quarter 2026 Results and Highlights
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share us

on your social networks:

Sign up for:

Healthcare Focus Minnesota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.